Trial Profile
A Safety and Tolerability Evaluation of Ascending Single Oral Doses of Metacavir Enteric-coated Capsules Using a Randomized Double-blind, Placebo-controlled Design Conducted in Chinese Healthy Adult Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Jun 2017
Price :
$35
*
At a glance
- Drugs Metacavir (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- Sponsors Guangzhou Yipinhong Pharmaceutical
- 05 Jun 2017 New trial record